Susan Erickson-viitanen

3 Patents

• US118967172024

  Sustained-release Dosage Forms of Ruxolitinib

  Incyte Corporation

  0 cites
• US115768642023

  Sustained-release Dosage Forms of Ruxolitinib

  Incyte Holdings Corporation

  0 cites
• US115768652023

  Sustained-release Dosage Forms of Ruxolitinib

  Incyte Holdings Comoration

  0 cites